Thrombogenic susceptibility in middle aged Veterans
中年退伍军人的血栓形成易感性
基本信息
- 批准号:10196967
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAdverse effectsAgeAge of OnsetAgingAgonistBioenergeticsBlood PlateletsBlood VesselsBlood coagulationCaringChronicDataDeacetylaseDevelopmentDiabetes MellitusElderlyElectron TransportEventExhibitsFutureHealth Care CostsHospitalizationHumanHyperactivityIncidenceLeadLifeMediatingMetabolicMitochondriaMitochondrial ProteinsMorbidity - disease rateMusMyocardial InfarctionObesityOutcomePatientsPhenotypePilot ProjectsPlatelet ActivationPrediabetes syndromePredispositionPrevention strategyProteinsQuality of lifeReactionReactive Oxygen SpeciesRegulationRiskRisk FactorsRoleSOD2 geneSirtuinsSourceStrokeSuperoxidesSystemTestingThrombosisThrombusTissuesVeteransVeterans Health Administrationage effectage relatedagedaging geneanti agingantioxidant enzymebaseburden of illnesscardiovascular risk factorcirculating biomarkerscohortearly onsethigh riskmetabolomicsmiddle agemortalitynovelplatelet functionstroke eventthrombogenesisthromboticthrombotic complications
项目摘要
A primary cause of morbidity and mortality in the elderly is thrombotic complications, including
myocardial infarction and stroke, and these events are the leading cause of hospitalization in
Veteran Health Administration (VA) system. However, the mechanisms of thrombosis due to
aging are understudied in VA patients. Secondly, risk factors that are encountered during mid-
life may exacerbate outcome or lead to an early event in life. For example, due to obesity
endemic the incidence of pre-diabetes in US is increasing, with current estimates indicating that
37% of adults are pre-diabetic. Amongst Veterans one in four have diabetes, and over 70% of
Veterans receiving VA care are obese. Likewise, a high incidence of prediabetes is also
apparent in VA patients. Given Veterans are at higher risk for cardiovascular events which are
frequently associated with previously undiagnosed diabetes, understanding early age-related
mechanisms in mid-life Veterans with or without prediabetes is necessary to develop preventive
strategies for future vascular events. We have established that increased thrombotic
susceptibility in middle-aged/older mice is associated with increased platelet activation and
reactive oxygen species (ROS) accumulation, though the underlying mechanisms are unclear.
In pilot studies, we have made the novel observation that sirtuin 3 (SIRT3), a well-established
anti-aging gene, is markedly decreased in platelets from aged vs. young human or mice. SIRT3
is a mitochondrial deacetylase that finely controls the activity of several electron transport chain
(ETC) proteins and superoxide dismutase 2 (SOD2) to cumulatively regulate ROS levels, but its
role in platelet activation is not clear. We have now generated proof of principle data
demonstrating that inhibition of SIRT3 leads to increased platelet activation and its activation
reduces aggregation. Therefore, our central hypothesis is that, in middle aged Veterans, loss
of SIRT3 promotes mitochondrial ROS accumulation in platelets, leading to platelet hyperactivity
and increased thrombotic susceptibility, and that this phenotype is accentuated by presence of
obesity and pre-diabetes. Specific Aim 1 will define the mechanistic role of SIRT3 in regulation
of mitochondrial ROS levels, platelet activation and increased thrombotic susceptibility in mid-
life Veterans. Specific Aim 2 will examine whether pre-diabetes modulates early-age onset of
SIRT3-mediated mitochondrial ROS accumulation, platelet hyperactivation and exacerbates
thrombotic susceptibility in mid-life Veterans.
老年人发病率和死亡率的主要原因是血栓并发症,包括
心肌梗死和中风,这些事件是#年住院的主要原因
退伍军人健康管理局(VA)系统。然而,由于血栓形成的机制
VA患者的衰老研究还不够深入。其次,年中遇到的风险因素
生活可能会加剧结果,或导致人生早期的事件。例如,由于肥胖
糖尿病前期在美国的发病率正在上升,目前的估计表明
37%的成年人是糖尿病前期。在退伍军人中,四分之一患有糖尿病,超过70%的人
接受退伍军人管理局护理的退伍军人都很肥胖。同样,糖尿病前期的高发病率也是
在VA患者中很明显。鉴于退伍军人发生心血管事件的风险更高,
经常与以前未诊断的糖尿病有关,了解早期年龄相关
有或没有糖尿病前期的中年退伍军人的机制对于制定预防措施是必要的
针对未来血管事件的策略。我们已经证实,血栓形成增加
中年/老年小鼠的易感性与血小板活化和
活性氧(ROS)的积累,尽管潜在的机制尚不清楚。
在初步研究中,我们做了一个新的观察到,sirtuin 3(SIRT3),一个公认的
与年轻人或小鼠相比,抗衰老基因在老年人的血小板中显著减少。SIRT3
是一种线粒体脱乙酰酶,可以精细地控制几个电子传输链的活性
(ETC)蛋白质和超氧化物歧化酶2(SOD2)累积调节ROS水平,但其
其在血小板活化中的作用尚不清楚。我们现在已经生成了原理数据的证明
证明抑制SIRT3导致血小板活化及其活化增加
减少聚合。因此,我们的中心假设是,在中年退伍军人中,
SIRT3促进线粒体ROS在血小板内积聚,导致血小板过度活动
并增加血栓易感性,而且这种表型因存在
肥胖和糖尿病前期。具体目标1将定义SIRT3在监管中的机械作用
线粒体ROS水平、血小板活化和血栓易感性增加的中期
退伍军人。特定目标2将检查糖尿病前期是否调节早期发病
SIRT3介导的线粒体ROS积聚、血小板过度激活和加重
中年退伍军人的血栓易感性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjana Dayal其他文献
Sanjana Dayal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjana Dayal', 18)}}的其他基金
Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility
SARS-CoV-2 在介导血栓易感性中的细胞作用
- 批准号:
10467274 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility
SARS-CoV-2 在介导血栓易感性中的细胞作用
- 批准号:
10569568 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Thrombogenic susceptibility in middle aged Veterans
中年退伍军人的血栓形成易感性
- 批准号:
10710160 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Thrombogenic susceptibility in middle aged Veterans
中年退伍军人的血栓形成易感性
- 批准号:
10409685 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Peroxide mediated prothrombotic effects of aging (Supplement)
过氧化物介导的衰老促血栓形成作用(补充)
- 批准号:
9522272 - 财政年份:2015
- 资助金额:
-- - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
-- - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




